A shareholder agreement only matters on the days no one wants to read it: the day a co-founder leaves, the day a buyer turns up, the day two directors stop speaking. On every other day it sits in a drive folder, unloved. The drafting effort, then, should concentrate on the handful of clauses that decide what actually happens on those days. In a UK private company limited by shares, four clauses do most of that work.
Everything else — confidentiality, boilerplate, notice provisions, the schedule of reserved matters — is scaffolding. Useful, occasionally decisive, but rarely the thing that determines whether founders keep their equity, whether minority investors get bought out fairly, or whether the company survives a fight at the top.
Pre-emption: who gets to buy what, and when
Pre-emption rights govern two distinct moments, and conflating them is the most common drafting error we see.
The first is pre-emption on issue: when the company issues new shares, existing shareholders get the right to subscribe pro rata before outsiders do. This protects against silent dilution. The Companies Act provides a statutory floor for this in many cases, but most shareholder agreements layer their own version on top, with carve-outs for employee option pools, agreed funding rounds, and acquisitions paid in stock.
The second is pre-emption on transfer: when an existing shareholder wants to sell, the others get first refusal. This is what keeps the cap table from drifting toward strangers — or toward a competitor who has quietly bought up a departing founder's stake.
The questions that decide whether these clauses work in practice are unglamorous:
- Is the price fixed by the seller, by an independent valuer, or by a formula?
- How long does the offer round run before the seller can go external?
- Do permitted transfers to family trusts, holding companies, or affiliates bypass the mechanism — and if so, with what guardrails?
- Are the pre-emption rights waivable only by a supermajority, or by the board?
A pre-emption clause that looks reasonable on paper can be neutered by a thirty-day window no minority shareholder can realistically fund, or by an "independent valuation" provision that names no valuer and no methodology.
Drag along and tag along: the exit clauses that pre-date any exit
Drag along and tag along provisions are the clauses that decide how a sale of the company actually happens — years before anyone has a buyer.
Drag along lets a defined majority force the remaining shareholders to sell on the same terms. Without it, a single recalcitrant minority can block a clean 100% sale, which most trade buyers insist on. Tag along lets minority shareholders piggy-back on a majority sale, so the founders cannot quietly sell their controlling block to a third party and leave the minority stranded with a new, unknown majority owner.
The drafting decisions that matter:
- The drag threshold. 50%? 75%? Holders of a specific share class? The lower the threshold, the easier the exit — and the less protection for everyone else.
- The terms imposed on the dragged. Are minority shareholders required to give the same warranties as the sellers driving the deal? Uncapped? This is where minority investors get hurt.
- Minimum price or valuation floors. A drag at any price is a confiscation mechanism. A drag above a stated floor is an exit mechanism.
- Tag scope. Does tag apply to any transfer above a threshold, or only to a change of control? Does it cover indirect transfers — sales of a parent holding company, for instance?
- Permitted transfer carve-outs. The same permitted-transfer list that softens pre-emption can also gut tag rights if drafted carelessly.
Drag along tag along provisions are where minority investors earn their fee, and where founders sometimes give away more than they realise in exchange for term-sheet speed.
Founder vesting: equity you have not yet earned
Founder vesting is the clause founders most resist and most often regret not having. The principle is straightforward: a founder's shares are subject to a buyback or compulsory transfer right if they leave the business before an agreed schedule completes.
A typical structure runs over three to four years, sometimes with a one-year cliff. What matters more than the schedule is the leaver classification: good leaver, bad leaver, and the increasingly common intermediate category.
- A good leaver (death, long-term illness, sometimes redundancy or removal without cause) typically keeps vested shares and is bought out of unvested shares at fair value.
- A bad leaver (resignation without cause, dismissal for gross misconduct, breach of restrictive covenants) typically forfeits unvested shares for nominal value and sometimes sees vested shares clawed back at a discount.
- The intermediate leaver category — fair value for vested, nominal for unvested — is where most negotiated outcomes land.
Two drafting points decide whether founder vesting functions as intended. First, who classifies the leaver: the board, a majority of shareholders, or an external arbiter? Founders should resist a structure where the people who will buy back the shares also decide the category. Second, what is "fair value" and who calculates it? An undefined fair value clause is a future dispute waiting to be had.
Deadlock: the clause that decides whether the company survives a fight
Deadlock provisions matter most in 50/50 companies and in any structure where a small number of holders can block reserved matters. They are routinely under-drafted because no one founding a company believes they will need them.
The standard escalation ladder runs: good-faith negotiation between principals, then mediation, then a structural mechanism. The structural mechanisms include:
- Russian roulette: one side offers a price; the other must either buy at that price or sell at that price.
- Texas shoot-out: both sides submit sealed bids; highest bid buys out the other.
- Casting vote: chair or a nominated director breaks the tie — workable for operational deadlock, dangerous for fundamental decisions.
- Independent expert determination: an external party decides the specific question.
- Wind-up: the nuclear option, sometimes the only honest answer.
The wrong deadlock mechanism for the wrong company can be worse than none. Russian roulette rewards the shareholder with deeper pockets, regardless of who is right. A casting vote handed to a non-executive chair can quietly hand them control of the company. Choose deliberately.
What to take from this
A UK shareholder agreement is not a document you draft once and file. The four clauses above interact with your articles of association, your option scheme, any investment agreement, and the directors' service contracts. Inconsistencies between these documents are where disputes start.
If you are structuring or restructuring a UK private company and want these clauses reviewed against your actual cap table and commercial intentions, Serene Jade's legal services include UK shareholder agreement drafting and review by qualified English solicitors, with bilingual support for cross-border founder teams.
FAQ
Q: We are two founders splitting 50/50 — do we really need vesting on ourselves? A: Yes, and arguably more than founders with unequal splits. A 50/50 company where one founder walks at month nine without vesting leaves the remaining founder running the business while the departed one keeps half the equity forever. Mutual vesting is the simplest protection.
Q: Can drag along be enforced against a shareholder who refuses to sign the share purchase agreement? A: A well-drafted drag clause typically grants a power of attorney to a designated party to sign transfer documents on the dragged shareholder's behalf, precisely to avoid this hold-out. Without that power-of-attorney mechanism, enforcement becomes a litigation problem rather than a transactional one.
Q: Our investor wants pre-emption rights on every future issue. Is that standard? A: Pro rata pre-emption on issue is standard for meaningful minority investors; the negotiation is usually over the carve-outs — option pool top-ups, agreed bridge financings, and shares issued as consideration in acquisitions are commonly excluded so the company is not paralysed by having to run a full pre-emption process for routine matters.